Browsing Tag
SOLARIS study
1 post
Medincell’s Phase 3 trial for long-acting injectable olanzapine in schizophrenia reaches completion
Medincell has announced the successful completion of the pivotal Phase 3 SOLARIS clinical trial for its long-acting injectable…